Prevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: A three-year retrospective study. 2018

Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
Laboratory Division, Ayder Comprehensive Specialized Hospital, Mekelle University, Mekelle, Ethiopia.

Blood transfusion services are a vital and integral part of modern healthcare services. However, the risk of transfusion transmittable infections (TTI) has been a major handicap. Therefore, this study was aimed at determining the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) among blood donors. A retrospective study was conducted to collect data about the blood donors who consecutively donated blood from October 2011 to 2014. A three-year retrospective study was conducted in Mekelle Blood Bank. A data abstraction format was used to collect the sociodemographic and clinical data, and the prevalence of HBV, HCV, and HIV was determined. Data were analyzed using STATA version 10 analytical software. P value less than 0.05 was considered significant in all the analyses. A total of 10 728 blood donors, median (interquartile range) of age 30 (23-45) years and 3750 (34.9%) males were enrolled in this study. Of the participants 407(3.79%), 143(1.33%), and 111(1.03%) blood donors were positive for HBV, HCV, and HIV, respectively. HBV-HIV coinfections were found 10 (1.93%) blood donors, followed by HBV-HCV and HIV-HCV. A significant association between sex and marital status with HBV and HIV infection was found. However, significant association of HCV was observed among sex ( X 2  = 33.18, P < 0.001) and occupational ( X 2  = 84.33, P < 0.001). A significant percentage of HBV, HCV, and HIV among blood donors was observed. To select a donor and collect safe blood risk factors exposing blood donor should be studied, and community-based prevalence studies on TTI are also required.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001771 Blood Banks Centers for collecting, characterizing and storing blood or plasma. Bank, Blood,Banks, Blood,Blood Bank
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D005002 Ethiopia An independent state in eastern Africa. Ethiopia is located in the Horn of Africa and is bordered on the north and northeast by Eritrea, on the east by Djibouti and Somalia, on the south by Kenya, and on the west and southwest by Sudan. Its capital is Addis Ababa. Federal Democratic Republic of Ethiopia
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
January 2020, Journal of blood medicine,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
March 2016, Ethiopian journal of health sciences,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
March 2021, JPMA. The Journal of the Pakistan Medical Association,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
December 2015, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
October 2009, Transfusion,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
March 2011, Ethiopian journal of health sciences,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
January 2012, Medecine et sante tropicales,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
March 2004, Indian journal of ophthalmology,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
April 2014, BMC infectious diseases,
Berhanu Degefa, and Teklehaymanot Gebreeyesus, and Zufan Gebremedhin, and Getachew Melkamu, and Atsebaha Gebrekidan, and Haftamu Hailekiros, and Ephrem Tsegay, and Selam Niguse, and Mahmud Abdulkader
July 2017, Journal of medical virology,
Copied contents to your clipboard!